Patent: 10,053,504
✉ Email this page to a colleague
Summary for Patent: 10,053,504
Title: | SPARC binding ScFvs |
Abstract: | The invention provides compositions comprising SPARC binding ScFv and its use. |
Inventor(s): | Trieu; Vuong (Agoura Hills, CA) |
Assignee: | ABRAXIS BIOSCIENCE, LLC (Los Angeles, CA) |
Application Number: | 15/132,647 |
Patent Claims: | see list of patent claims |
Details for Patent 10,053,504
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2028-12-05 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2028-12-05 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | ⤷ Try a Trial | 2028-12-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |